TransUnion (NYSE: TRU) Navigates Mortgage Market with VantageScore Pricing Strategy

• TransUnion (NYSE: TRU)'s VantageScore 4.0 mortgage scores are priced at $0.99 until December 2028, offering certainty to lenders amidst competition.
• The extension of VantageScore 4.0 availability by the Federal Housing Finance Agency to Fannie Mae and Freddie Mac lenders enhances its competitive position against FICO scores.
• Despite a "price war" headline, TransUnion's strategy focuses on consistent pricing and expanded access for its credit scoring product.

TransUnion (NYSE: TRU) is a leading credit reporting company that also provides essential credit scores to lenders. Morgan Stanley currently maintains an Overweight grade on the stock, with the action listed as hold. At the time of this update, TransUnion stock trades at $65.22.

TransUnion actively competes with Fair Isaac, the company behind widely used FICO scores, particularly within the crucial mortgage market. As highlighted by Benzinga, potential changes in how Fannie Mae and Freddie Mac price credit scores could significantly ease the adoption of VantageScore over FICO Classic for lenders. While Benzinga’s headline suggests a TransUnion price war, its accompanying article provides no specific details regarding TransUnion’s actual pricing strategy.

TransUnion has confirmed that its VantageScore 4.0 mortgage scores will remain priced at $0.99 each when purchased separately, a rate guaranteed through December 2028. This competitive pricing ensures that mortgage customers who opt for a FICO score will still receive VantageScore 4.0 at no additional cost. This strategic extension provides lenders and mortgage resellers with greater certainty regarding their expenditures for credit scores.

This significant pricing extension is a direct result of a September 2026 decision by the Federal Housing Finance Agency to broaden the availability of VantageScore 4.0 to approved Fannie Mae and Freddie Mac lenders. In a recent market snapshot, TransUnion stock (TRU) was trading at $64.11, marking an increase of $1.93, or 3.10%. The stock’s 52-week range spans from $60.96 to $89.12.